ScoreWhy is CorMedix, Inc. ?
1
With a growth in Operating Profit of 24.87%, the company declared Very Positive results in Sep 25
- The company has declared positive results for the last 3 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 74.98 MM
- ROCE(HY) Highest at 75.08%
- NET SALES(Q) Highest at USD 104.28 MM
2
With ROE of 43.25%, it has a very attractive valuation with a 1.38 Price to Book Value
- Over the past year, while the stock has generated a return of 0.00%, its profits have risen by 450.6% ; the PEG ratio of the company is 0
3
Rising Promoter Confidence
- Promoters have increased their stake in the company by 1.01% over the previous quarter and currently hold 1.5% of the company
- Promoters increasing their stake is a sign of high confidence in the future of the business
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to CorMedix, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is CorMedix, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
CorMedix, Inc.
15.65%
0.22
74.21%
S&P 500
16.08%
0.62
19.30%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
192.77%
EBIT Growth (5y)
42.72%
EBIT to Interest (avg)
-25.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.32
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
71.10%
ROCE (avg)
7.71%
ROE (avg)
2.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
3
Industry P/E
Price to Book Value
1.38
EV to EBIT
4.45
EV to EBITDA
4.27
EV to Capital Employed
1.45
EV to Sales
2.16
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
32.50%
ROE (Latest)
43.25%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend43What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 74.98 MM
ROCE(HY)
Highest at 75.08%
NET SALES(Q)
Highest at USD 104.28 MM
CASH AND EQV(HY)
Highest at USD 246.43 MM
OPERATING PROFIT(Q)
Highest at USD 55.14 MM
OPERATING PROFIT MARGIN(Q)
Highest at 52.88 %
PRE-TAX PROFIT(Q)
Highest at USD 51.89 MM
NET PROFIT(Q)
Highest at USD 107.87 MM
EPS(Q)
Highest at USD 1.26
-13What is not working for the Company
INTEREST(HY)
At USD 0.95 MM has Grown at 5,665.34%
DEBT-EQUITY RATIO
(HY)
Highest at -13.72 %
RAW MATERIAL COST(Y)
Grown by 5.11% (YoY
Here's what is working for CorMedix, Inc.
Net Sales
At USD 104.28 MM has Grown at 243.34%
over average net sales of the previous four periods of USD 30.37 MMMOJO Watch
Near term sales trend is extremely positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 51.89 MM has Grown at 301.58%
over average net sales of the previous four periods of USD 12.92 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 107.87 MM has Grown at 743.42%
over average net sales of the previous four periods of USD 12.79 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
Highest at USD 104.28 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Operating Cash Flow
Highest at USD 74.98 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit
Highest at USD 55.14 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 52.88 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD 51.89 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 107.87 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD 1.26
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Cash and Eqv
Highest at USD 246.43 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Depreciation
Highest at USD 3.79 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Depreciation
At USD 3.79 MM has Grown at 2,226.28%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (USD MM)
Here's what is not working for CorMedix, Inc.
Interest
At USD 0.95 MM has Grown at 5,665.34%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Debt-Equity Ratio
Highest at -13.72 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 5.11% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
